Published in Biochem Biophys Res Commun on December 07, 1977
Localization of SV40 genes within supercoiled loop domains. Nucleic Acids Res (1980) 1.68
The association of transcriptionally active genes with the nuclear matrix of the chicken oviduct. Nucleic Acids Res (1983) 1.17
Enrichment of estradiol-receptor complexes in a transcriptionally active fraction of chromatin from MCF-7 cells. Proc Natl Acad Sci U S A (1980) 1.05
Nuclear estrogen receptor molecular heterogeneity in the mouse uterus. Proc Natl Acad Sci U S A (1988) 0.87
Distribution of estradiol receptor and vitellogenin gene in chick liver chromatin fractions. Nucleic Acids Res (1979) 0.84
Binding of androgens to a nuclear-envelope fraction from the rat ventral prostate. Biochem J (1980) 0.83
Nuclear association states of rat uterine oestrogen receptors as probed by nuclease digestion. Biochem J (1981) 0.77
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
The development of human benign prostatic hyperplasia with age. J Urol (1984) 8.29
Identification of a nuclear protein matrix. Biochem Biophys Res Commun (1974) 5.41
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
A fixed site of DNA replication in eucaryotic cells. Cell (1980) 3.78
Nuclear protein matrix: association with newly synthesized DNA. Science (1975) 3.27
Nuclear matrix. Isolation and characterization of a framework structure from rat liver nuclei. J Cell Biol (1977) 3.26
Supercoiled loops and eucaryotic DNA replicaton. Cell (1980) 3.24
Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol (1986) 3.07
Genomic exclusion: a rapid means for inducing homozygous diploid lines in Tetrahymena pyriformis, syngen 1. Science (1967) 2.86
Cytogenetics of genomic exclusion in Tetrahymena. Genetics (1967) 2.45
Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood (1991) 2.35
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl (1989) 2.12
The role of the nuclear matrix in the organization and function of DNA. Annu Rev Biophys Biophys Chem (1986) 2.07
DNA packaging and organization in mammalian spermatozoa: comparison with somatic cells. Biol Reprod (1991) 1.99
Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. Exp Cell Res (1981) 1.99
Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res (1996) 1.87
Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res (1981) 1.80
Electrophysiological and other aspects of the relaxant action of isoprenaline in guinea-pig isolated trachealis. Br J Pharmacol (1985) 1.69
The prostate: an increasing medical problem. Prostate (1990) 1.67
The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. J Biol Chem (1980) 1.66
Stem cell features of benign and malignant prostate epithelial cells. J Urol (1998) 1.62
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol (1998) 1.57
Genetic and epigenetic control of several isozymic systems in Tetrahymena. Ann N Y Acad Sci (1968) 1.55
Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci U S A (1989) 1.55
The epidemiology of prostate cancer in Jamaica. J Urol (1998) 1.53
Future prospects in prostate cancer. Prostate (1999) 1.53
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood (2001) 1.47
Polymerization of deoxyribonucleotides in relation to androgen-induced prostatic growth. Arch Biochem Biophys (1968) 1.43
A structural analysis of the role of the nuclear matrix and DNA loops in the organization of the nucleus and chromosome. J Cell Sci Suppl (1984) 1.43
The preparation of congenic strains of Tetrahymena. J Protozool (1971) 1.43
The nuclear protein matrix: isolation, structure, and functions. Adv Enzyme Regul (1976) 1.41
Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer (1991) 1.39
Interaction between tetraethylthiuram disulfide and the sulfhydryl groups of D-amino acid oxidase and of hemoglobin. J Biol Chem (1966) 1.38
The occurrence and distribution of burnout among infectious diseases physicians. J Infect Dis (1992) 1.38
Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res (1991) 1.35
Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. Cancer Res (1988) 1.32
The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol (1988) 1.32
Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature (1986) 1.31
Intersyngenic variations in the esterases of bacterized Paramecium aurelia. Biochem Genet (1971) 1.30
Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A (1992) 1.28
Nuclear-cytoskeletal interactions: evidence for physical connections between the nucleus and cell periphery and their alteration by transformation. J Cell Biochem (1992) 1.27
Mechanical and electrical aspects of the relaxant action of aminophylline in guinea-pig isolated trachealis. Br J Pharmacol (1986) 1.27
The relaxant action of nicorandil in guinea-pig isolated trachealis. Br J Pharmacol (1986) 1.27
Correlation of nuclear morphometry with progression of breast cancer. Cancer (1991) 1.26
Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer (1993) 1.24
Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res (1989) 1.24
The relationship of the nuclear matrix to cellular structure and function. Adv Enzyme Regul (1978) 1.23
Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol (1992) 1.21
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest (1979) 1.20
A sensitive radioassay for sulfhydryl groups with tetraethylthiuram disulfide. J Biol Chem (1966) 1.20
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology (1999) 1.18
Randomized clinical trial of a quality improvement intervention in nursing homes. Gerontologist (2001) 1.18
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis. Br J Pharmacol (1985) 1.17
Nuclear structure and the three-dimensional organization of DNA. J Cell Biochem (1991) 1.16
Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res (1997) 1.14
Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metab (1983) 1.14
Social policy implications of physician shortage areas in Missouri. Am J Public Health (1984) 1.14
A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res (1993) 1.12
Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT. Cancer Res (1978) 1.11
The 5S ribosomal RNA gene clusters in Tetrahymena thermophila: strain differences, chromosomal localization, and loss during micronuclear ageing. Mol Gen Genet (1984) 1.11
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol (1997) 1.10
The interaction of natural and synthetic polyanions with mammalian nucleo. I. DNA synthesis. Biochim Biophys Acta (1970) 1.06
Infectious disease manpower in the United States--1986. 1. Description of infectious disease physicians. Manpower and Training Committee, Infectious Diseases Society of America. J Infect Dis (1992) 1.06
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res (1995) 1.06
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect (2001) 1.05
Prostate tumor biology and cell kinetics--theory. Urology (1981) 1.05
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res (1993) 1.05
The nuclear matrix of the prostate contains acceptor sites for androgen receptors. Endocrinology (1983) 1.05
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer (1992) 1.05
Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res (1982) 1.04
Immunologic implications of vasectomy. II. Serum-mediated immunity. Fertil Steril (1974) 1.04
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann Intern Med (1982) 1.03
Setting thresholds for quality indicators derived from MDS data for nursing home quality improvement reports: an update. Jt Comm J Qual Improv (2000) 1.02
Sex steroid imprinting of the immature prostate. Long-term effects. Invest Urol (1978) 1.01
Nursing home care quality: a multidimensional theoretical model integrating the views of consumers and providers. J Nurs Care Qual (1999) 1.01
Intersyngenic variations in the esterases of axenic stocks of Paramecium aurelia. Biochem Genet (1971) 1.01
Sperm granulomas: an adverse effect of vasectomy. J Urol (1973) 1.00
Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate (1982) 1.00
Cell structure and DNA organization. Crit Rev Eukaryot Gene Expr (1991) 1.00
Sterility in male animals induced by injection of chemical agents into the vas deferens. Fertil Steril (1973) 0.99
Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. Cancer Treat Rep (1977) 0.99
A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J Urol (1982) 0.99
DNA loop domains in mammalian spermatozoa. Chromosoma (1989) 0.99
The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor. Invest Urol (1981) 0.98
Effects of neonatal steroids on male sex tissues. Invest Urol (1979) 0.98
Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer (1992) 0.98
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J Urol (1989) 0.98
Clostridium sordellii bacteremia: case report and review. Clin Infect Dis (1992) 0.98
Studies on crystalline D-amino acid oxidase. V. Characterization of borohydride-reduced enzyme-subtrate intermediate. Synthesis of epsilon-N-(1-carboxyethyl)-L-lysine. J Biol Chem (1967) 0.97
Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors. Am J Med (1987) 0.97
Inheritance of esterases A and B in syngen 2 of Paramecium aurelia. Genetics (1972) 0.97
The interaction of natural and synthetic polyanions with mammalian nucleo. II. Nuclear swelling. Biochim Biophys Acta (1970) 0.97
Alternative processing of sequences during macronuclear development in Tetrahymena thermophila. J Protozool (1986) 0.97
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood (1996) 0.97